Literature DB >> 26021418

The quality of life in long-term breast cancer survivors with breast cancer related lymphedema.

T R Lopez Penha1, J van Bodegraven, B Winkens, E M Heuts, A C Voogd, M F von Meyenfeldt.   

Abstract

AIM: To compare the health related quality of life (HRQOL) of long-term breast cancer survivors with and without breast cancer related lymphedema (BCRL) treated in the sentinel lymph node biopsy (SLNB) era.
METHODS: HRQOL was assessed as subject of a secondary analysis of data gathered for a study evaluating the prevalence of BCRL in long-term breast cancer survivors. The 145 women in this study cohort had undergone SLNB and or axillary lymph node dissection (ALND) according to Dutch Breast cancer treatment guidelines. HRQOL was assessed using two questionnaires : the European Organization for Research and Treatment of Cancer Quality (QLQ-C30) and the Breast Cancer-specific Quality of life questionnaire (QLQ-BR23).
RESULTS: Twenty-six women, of whom 5 only underwent SLNB, were identified with objectively measured lymphedema and/or self-perceived arm swelling. Patients with BCRL scored significantly lower on the social (p = 0.000) functioning scale after adjustment for BMI and age compared to women without BCRL. Compared to normative data, women with BCRL scored significantly lower on social- (p < 0.001) and role (p = 0.001) functioning scales.
CONCLUSIONS: HRQOL in long-term breast cancer survivors with BCRL is structurally lower than of those without BCRL, even in this small cohort of cancer survivors treated in the SLNB-era. Copyright© Acta Chirurgica Belgica.

Entities:  

Mesh:

Year:  2014        PMID: 26021418

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  2 in total

Review 1.  Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review.

Authors:  L H Eaton; N Narkthong; J M Hulett
Journal:  Curr Breast Cancer Rep       Date:  2020-08-25

2.  Vascularized lymph node transplantation successfully reverses lymphedema and maintains immunity in a rat lymphedema model.

Authors:  Ahmet Hamdi Sakarya; Chi-Wei Huang; Chin-Yu Yang; Hui-Yi Hsiao; Frank Chun-Shin Chang; Jung-Ju Huang
Journal:  Bioeng Transl Med       Date:  2022-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.